First Pacific Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $109M | Buy |
221,896
+3,324
| +2% | +$1.8M | 1.53% | 24 |
|
|
2025
Q4 | $127M | Buy |
218,572
+3,626
| +2% | +$2.05M | 1.67% | 22 |
|
|
2025
Q3 | $104M | Buy |
214,946
+127,576
| +146% | +$59.4M | 1.44% | 26 |
|
|
2025
Q2 | $35.4M | Buy |
+87,370
| New | +$36.5M | 0.51% | 36 |
|
|
2023
Q3 | – | Sell |
-650
| Closed | -$339K | – | 123 |
|
|
2023
Q2 | $339K | Hold |
650
| – | – | 0.01% | 89 |
|
|
2023
Q1 | $375K | Hold |
650
| – | – | 0.01% | 94 |
|
|
2022
Q4 | $358K | Hold |
650
| – | – | 0.01% | 126 |
|
|
2022
Q3 | $330K | Hold |
650
| – | – | 0.01% | 142 |
|
|
2022
Q2 | $353K | Sell |
650
-1,140
| -64% | -$627K | 0.01% | 139 |
|
|
2022
Q1 | $1.06M | Sell |
1,790
-179
| -9% | -$103K | 0.01% | 104 |
|
|
2021
Q4 | $1.31M | Sell |
1,969
-310
| -14% | -$194K | 0.02% | 96 |
|
|
2021
Q3 | $1.3M | Hold |
2,279
| – | – | 0.02% | 109 |
|
|
2021
Q2 | $1.15M | Hold |
2,279
| – | – | 0.01% | 105 |
|
|
2021
Q1 | $1.04M | Hold |
2,279
| – | – | 0.01% | 61 |
|
|
2020
Q4 | $1.06M | Sell |
2,279
-71
| -3% | -$33.3K | 0.01% | 97 |
|
|
2020
Q3 | $1.04M | Hold |
2,350
| – | – | 0.01% | 89 |
|
|
2020
Q2 | $851K | Hold |
2,350
| – | – | 0.01% | 93 |
|
|
2020
Q1 | $666K | Hold |
2,350
| – | – | 0.01% | 98 |
|
|
2019
Q4 | $763K | Hold |
2,350
| – | – | 0.01% | 97 |
|
|
2019
Q3 | $684K | Hold |
2,350
| – | – | 0.01% | 100 |
|
|
2019
Q2 | $690K | Hold |
2,350
| – | – | 0.01% | 97 |
|
|
2019
Q1 | $643K | Hold |
2,350
| – | – | 0.01% | 103 |
|
|
2018
Q4 | $526K | Sell |
2,350
-193,312
| -99% | -$45.4M | 0.01% | 106 |
|
|
2018
Q3 | $47.8M | Sell |
195,662
-1,053,044
| -84% | -$242M | 0.35% | 38 |
|
|
2018
Q2 | $259M | Sell |
1,248,706
-80,403
| -6% | -$17.1M | 1.86% | 25 |
|
|
2018
Q1 | $274M | Sell |
1,329,109
-8,961
| -0.7% | -$1.88M | 2.09% | 22 |
|
|
2017
Q4 | $254M | Buy |
1,338,070
+8,190
| +0.6% | +$1.57M | 1.9% | 22 |
|
|
2017
Q3 | $252M | Sell |
1,329,880
-132,640
| -9% | -$24M | 1.93% | 22 |
|
|
2017
Q2 | $255M | Buy |
1,462,520
+21,450
| +1% | +$3.6M | 1.93% | 23 |
|
|
2017
Q1 | $221M | Sell |
1,441,070
-19,030
| -1% | -$2.91M | 1.78% | 21 |
|
|
2016
Q4 | $206M | Sell |
1,460,100
-216,050
| -13% | -$31.9M | 1.64% | 22 |
|
|
2016
Q3 | $267M | Sell |
1,676,150
-112,680
| -6% | -$17.4M | 2.21% | 17 |
|
|
2016
Q2 | $264M | Buy |
1,788,830
+99,770
| +6% | +$14.7M | 2.23% | 16 |
|
|
2016
Q1 | $239M | Sell |
1,689,060
-143,350
| -8% | -$19.2M | 2.17% | 16 |
|
|
2015
Q4 | $260M | Sell |
1,832,410
-101,140
| -5% | -$13.5M | 2.31% | 14 |
|
|
2015
Q3 | $236M | Sell |
1,933,550
-1,514,850
| -44% | -$197M | 2.04% | 13 |
|
|
2015
Q2 | $447M | Buy |
3,448,400
+37,600
| +1% | +$4.9M | 3.65% | 7 |
|
|
2015
Q1 | $458M | Sell |
3,410,800
-206,600
| -6% | -$26.6M | 3.81% | 8 |
|
|
2014
Q4 | $453M | Buy |
3,617,400
+67,700
| +2% | +$8.23M | 3.61% | 7 |
|
|
2014
Q3 | $432M | Buy |
3,549,700
+28,500
| +0.8% | +$3.47M | 3.59% | 5 |
|
|
2014
Q2 | $416M | Buy |
3,521,200
+12,100
| +0.3% | +$1.42M | 3.37% | 7 |
|
|
2014
Q1 | $422M | Sell |
3,509,100
-402,800
| -10% | -$47.9M | 3.69% | 5 |
|
|
2013
Q4 | $436M | Buy |
3,911,900
+5,800
| +0.1% | +$577K | 4.1% | 5 |
|
|
2013
Q3 | $360M | Buy |
3,906,100
+5,800
| +0.1% | +$525K | 3.72% | 6 |
|
|
2013
Q2 | $330M | Buy |
+3,900,300
| New | +$325M | 3.52% | 5 |
|
Other funds holding TMO
VCM
First Pacific Advisors's TMO Position: Q1 2026 in Review
First Pacific Advisors increased its Thermo Fisher Scientific (TMO) stake by 1.5% in Q1 2026, buying an estimated $1.8M and bringing the position to 221,896 shares worth $109M. The position accounts for 1.53% of the portfolio, ranked #24.
First Pacific Advisors first reported a position in TMO in Q2 2013 and has held it in 45 quarters since. The position peaked at $458M in Q1 2015. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- First Pacific Advisors held 221,896 shares of Thermo Fisher Scientific worth $109M as of Q1 2026.
- First Pacific Advisors bought 3,324 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.8M.
- Thermo Fisher Scientific made up 1.53% of First Pacific Advisors's portfolio in Q1 2026, its #24 holding.
- First Pacific Advisors first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 45 quarters since.
- First Pacific Advisors's Thermo Fisher Scientific position peaked at $458M in Q1 2015.
- 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on First Pacific Advisors's 13F filing for Q1 2026, filed 14 May 2026.